Experimental ceramide therapy takes on tough leukemia
Disease control
Recruiting now
This early-stage trial tests a new drug called C6 ceramide nanoliposome (Ceraxa) in 15 adults with acute myeloid leukemia that has come back or not responded to treatment. The drug is given by IV twice a week, and the main goal is to check safety and find the right dose. It is to…
Phase: PHASE1 • Sponsor: Keystone Nano, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC